Código QR (código de barras bidimensional)

Advances in Pseudoprogression of Immune Checkpoint Inhibitors 
in Non-small Cell Lung Cancer

The advent of immune checkpoint inhibitors (ICIs) has greatly improved the prognosis of advanced lung cancer patients, but can lead to pseudoprogression (PsP), which complicates clinical evaluation and management. PsP is manifested as temporary enlargement of the tumour or the appearance of new lesi...

ver descrição completa

Na minha lista:
Principais autores: Yajun TONG, Yong LONG, Fan ZHANG, Junfeng LI
Formato: Artigo
Idioma:Chinês
Publicado em: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-04-01
coleção:Chinese Journal of Lung Cancer
Assuntos:
lung neoplasms
immune checkpoint inhibitors
pseudoprogression
immunotherapy
Acesso em linha:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados